What is Langaware?
Langaware operates at the intersection of artificial intelligence and clinical diagnostics, specializing in the analysis of speech and voice biomarkers to identify cognitive and behavioral health conditions. By deploying advanced machine learning algorithms, the company provides healthcare professionals with objective, data-driven insights that facilitate early intervention. This technological approach aims to alleviate the systemic burden on healthcare providers while simultaneously improving patient outcomes through personalized care pathways. As a pioneer in the field, Langaware is effectively bridging the gap between complex neurological health data and actionable clinical intelligence, positioning itself as a critical player in the evolving landscape of AI-enabled medical diagnostics.
How much funding has Langaware raised?
Langaware has raised a total of $2.1M across 1 funding round:
Angel/Seed
$2.1M
Angel/Seed (2023): $2.1M with participation from Metavallon VC and Eleven Ventures
Key Investors in Langaware
Metavallon VC
A venture capital firm specializing in early-stage technology investments with a focus on deep tech and scalable software solutions.
Eleven Ventures
A prominent early-stage investment firm that supports ambitious founders in the CEE region, focusing on fintech, healthcare, and enterprise software.
What's next for Langaware?
Following this major enterprise-level funding, Langaware is expected to prioritize the expansion of its clinical validation studies and the commercial deployment of its diagnostic tools. The influx of capital will likely be directed toward enhancing the sensitivity of its speech biomarker models and integrating these solutions into broader electronic health record systems. By focusing on scalability and regulatory compliance, the company aims to solidify its market presence and establish new standards for objective cognitive assessment. Future growth will likely hinge on strategic partnerships with healthcare institutions and the continued refinement of its AI architecture to address a wider spectrum of neurological and behavioral health challenges.
See full Langaware company page
